Prospective study of transfusion associated hepatitis in thalassemic children after the introduction of anti-HCV donor screening

Bone Marrow Transplantation

Volumn 19, Issue SUPPL. 2, 1997, Pages 158-159

  Lai, M E ^a   Argiolu, F ^a   Balaci, L ^a   Mazzoleni, A P ^b   Lisci, V ^a   Mandas, A ^a   Ruvoletto, L ^a   Farci, P ^b   Balestrieri, A ^a   De Virgiliis, S ^a   Cao, A ^a  

^a Osp Regionale per le Microcitemie   (Italy)

^b Istituto di Medicina Interna   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING; THALASSEMIA;

EID: 0030947818     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. Lai ME, De Virgiliis S, Argiolu F, et al. Evaluation of antibodies to hepatitis C virus in long-term prospective study of posttransfusion hepatitis among thalassemic children. J Pediatr Gastroenterol Nutr 1993; 16:458-64.
2. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet 1994; 343:338-90.
3. Simons JN, Leary TP, Dawson GJ, et al. Isolation of a novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1:564-9.
4. Linnen J, Wages J Jr, Zhang-Keck ZY, et al. Molecular cloning and disease association of hepatitis G virus: a transfusion trasmissible agent. Science 1996; 271:505-8.
5. Alter HJ. The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 1996; 334:1536-7.